[BSTEAD] QoQ Quarter Result on 31-Mar-2016 [#1]

Stock
[BSTEAD] BOUSTEAD HOLDINGS BHD
Announcement Date
25-May-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Mar-2016 [#1]
Profit Trend
QoQ- -611.9%
YoY- -21600.0%
Quarter Report
Latest QR
Upcoming QR
BSTEAD's Result
BSTEAD's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 2,422,200 2,023,400 2,069,000 1,856,700 2,442,300 2,120,300 2,207,600 6.35%
PBT 261,200 120,400 341,100 36,300 49,700 66,700 83,300 113.49%
Tax -76,300 -27,100 -39,700 -26,800 -50,500 -20,400 -32,500 76.18%
NP 184,900 93,300 301,400 9,500 -800 46,300 50,800 135.69%
-
NP to SH 120,700 44,000 225,800 -21,500 4,200 6,000 2,900 1087.49%
-
Tax Rate 29.21% 22.51% 11.64% 73.83% 101.61% 30.58% 39.02% -
Total Cost 2,237,300 1,930,100 1,767,600 1,847,200 2,443,100 2,074,000 2,156,800 2.46%
-
Net Worth 6,891,800 6,912,070 7,983,165 5,705,769 5,695,609 5,793,103 5,862,142 11.33%
Dividend
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Div 70,945 101,350 66,804 51,682 40,975 62,068 51,785 23.23%
Div Payout % 58.78% 230.34% 29.59% 0.00% 975.61% 1,034.48% 1,785.71% -
Equity
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Net Worth 6,891,800 6,912,070 7,983,165 5,705,769 5,695,609 5,793,103 5,862,142 11.33%
NOSH 2,027,000 2,027,000 1,670,118 1,033,653 1,024,390 1,034,482 1,035,714 56.14%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 7.63% 4.61% 14.57% 0.51% -0.03% 2.18% 2.30% -
ROE 1.75% 0.64% 2.83% -0.38% 0.07% 0.10% 0.05% -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 119.50 99.82 123.88 179.62 238.42 204.96 213.15 -31.88%
EPS 5.95 2.17 13.52 -2.08 0.41 0.58 0.28 660.12%
DPS 3.50 5.00 4.00 5.00 4.00 6.00 5.00 -21.07%
NAPS 3.40 3.41 4.78 5.52 5.56 5.60 5.66 -28.69%
Adjusted Per Share Value based on latest NOSH - 1,033,653
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 119.50 99.82 102.07 91.60 120.49 104.60 108.91 6.35%
EPS 5.95 2.17 11.14 -1.06 0.21 0.30 0.14 1104.08%
DPS 3.50 5.00 3.30 2.55 2.02 3.06 2.55 23.38%
NAPS 3.40 3.41 3.9384 2.8149 2.8099 2.858 2.892 11.33%
Price Multiplier on Financial Quarter End Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 -
Price 2.67 2.16 2.71 3.93 4.30 3.95 4.15 -
P/RPS 2.23 2.16 2.19 2.19 1.80 1.93 1.95 9.31%
P/EPS 44.84 99.51 20.04 -188.94 1,048.78 681.03 1,482.14 -90.18%
EY 2.23 1.00 4.99 -0.53 0.10 0.15 0.07 894.44%
DY 1.31 2.31 1.48 1.27 0.93 1.52 1.20 5.99%
P/NAPS 0.79 0.63 0.57 0.71 0.77 0.71 0.73 5.38%
Price Multiplier on Announcement Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 28/02/17 30/11/16 24/08/16 25/05/16 29/02/16 30/11/15 24/08/15 -
Price 2.83 2.19 2.25 2.84 4.08 4.07 4.10 -
P/RPS 2.37 2.19 1.82 1.58 1.71 1.99 1.92 14.99%
P/EPS 47.53 100.89 16.64 -136.54 995.12 701.72 1,464.29 -89.71%
EY 2.10 0.99 6.01 -0.73 0.10 0.14 0.07 855.58%
DY 1.24 2.28 1.78 1.76 0.98 1.47 1.22 1.08%
P/NAPS 0.83 0.64 0.47 0.51 0.73 0.73 0.72 9.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment